Zhou, T; Georgeon, S; Moser, R; Moore, D J; Caflisch, A; Hantschel, O (2014). Specificity and mechanism-of-action of the JAK2 tyrosine kinase inhibitors ruxolitinib and SAR302503 (TG101348). Leukemia, 28(2):404-407.
Statistics
Citations
Dimensions.ai Metrics
Altmetrics
Downloads
0 downloads since deposited on 01 Jul 2014
0 downloads since 12 months
0 downloads since 12 months
Additional indexing
| Item Type: | Journal Article, refereed, original work |
|---|---|
| Communities & Collections: | 04 Faculty of Medicine > Department of Biochemistry
07 Faculty of Science > Department of Biochemistry |
| Dewey Decimal Classification: | 570 Life sciences; biology |
| Scopus Subject Areas: | Health Sciences > Hematology
Health Sciences > Oncology Life Sciences > Cancer Research |
| Language: | English |
| Date: | 2014 |
| Deposited On: | 01 Jul 2014 15:43 |
| Last Modified: | 24 Jan 2022 04:23 |
| Publisher: | Nature Publishing Group |
| ISSN: | 0887-6924 |
| OA Status: | Closed |
| Free access at: | Publisher DOI. An embargo period may apply. |
| Publisher DOI: | https://doi.org/10.1038/leu.2013.205 |
| PubMed ID: | 23823659 |
Zhou, T